Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Ipsen S.A. ADR (IPSEY)

Ipsen S.A. ADR (IPSEY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 11,770,909
  • Shares Outstanding, K 335,258
  • Annual Sales, $ 3,868 M
  • Annual Income, $ 374,300 K
  • EBIT $ 0 M
  • EBITDA $ 1,301 M
  • 60-Month Beta 0.43
  • Price/Sales 3.12
  • Price/Cash Flow N/A
  • Price/Book 2.45
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 02/13/25
  • Annual Dividend & Yield 0.26 (0.74%)
  • Most Recent Dividend 0.259 on 06/09/25
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/25
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
34.9500 +0.46%
on 12/04/25
38.9500 -9.86%
on 11/14/25
-0.9665 (-2.68%)
since 11/04/25
3-Month
32.0200 +9.65%
on 09/26/25
38.9500 -9.86%
on 11/14/25
+1.4025 (+4.16%)
since 09/02/25
52-Week
25.1100 +39.82%
on 04/21/25
38.9500 -9.86%
on 11/14/25
+6.7700 (+23.89%)
since 12/04/24

Most Recent Stories

More News
Ipsen and Medison Pharma Announce Health Canada Approval of Bylvayâ„¢ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

/CNW/ -- Today, Ipsen (Euronext: IPN) (ADR: IPSEY), a global biopharmaceutical company focused on transformative medicines in oncology, rare disease and...

IPN : 34.71 (-0.54%)
IPSEY : 35.1100 (-2.55%)
Ipsen Receives CHMP Negative Opinion for Palovarotene as a Treatment for Fibrodysplasia Ossificans Progressiva in E.U.

Regulatory News:

OTC.VN : 0.750 (+1.35%)
IPN : 34.71 (-0.54%)
IPSEY : 35.1100 (-2.55%)
Ipsen Presents Phase III NAPOLI 3 Trial of Onivyde® Regimen Demonstrating Positive Survival Results in Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma at ASCO GI

Regulatory News:

OTC.VN : 0.750 (+1.35%)
IPN : 34.71 (-0.54%)
IPSEY : 35.1100 (-2.55%)
Why These Two Biotech Stocks Blasted Higher This Week

There's nothing like a big-premium buyout to send a company's share price to the moon.

CINC : 29.06 (-0.48%)
AZN : 90.54 (+0.40%)
ALBO : 44.15 (-0.23%)
IPSEY : 35.1100 (-2.55%)
SHAREHOLDER ALERT: Weiss Law Investigates Albireo Pharma, Inc.

/PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Albireo Pharma, Inc....

ALBO : 44.15 (-0.23%)
IPSEY : 35.1100 (-2.55%)
2 Tiny Nasdaq Stocks Making Major Merger Moves Monday

The market is moving higher, and these small companies are helping.

COMP : 10.44 (+1.16%)
$NASX : 23,514.33 (-0.27%)
DCT : 18.99 (unch)
ALBO : 44.15 (-0.23%)
IPSEY : 35.1100 (-2.55%)
Ipsen to Acquire Albireo Accelerating Growth in Rare Disease With Treatments for Several Pediatric Liver Diseases

Regulatory News:

OTC.VN : 0.750 (+1.35%)
ALBO : 44.15 (-0.23%)
IPN : 34.71 (-0.54%)
IPSEY : 35.1100 (-2.55%)
Ipsen receives Complete Response Letter for palovarotene, an investigational treatment for fibrodysplasia ossificans progressiva

Regulatory News:

OTC.VN : 0.750 (+1.35%)
IPN : 34.71 (-0.54%)
IPSEY : 35.1100 (-2.55%)
Ipsen Provides Update On Phase III CONTACT-01 Trial Evaluating Cabozantinib in Combination With Atezolizumab in Patients With Metastatic Non-small Cell Lung Cancer Previously Treated With Immunotherapy and Chemotherapy

Regulatory News:

OTC.VN : 0.750 (+1.35%)
IPN : 34.71 (-0.54%)
IPSEY : 35.1100 (-2.55%)
Onivyde® Regimen Demonstrated Statistically Significant Improvement in Overall Survival in Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma

Regulatory News:

OTC.VN : 0.750 (+1.35%)
IPN : 34.71 (-0.54%)
IPSEY : 35.1100 (-2.55%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

Ipsen S.A. is a pharmaceutical company. It provide drugs for urology, oncology, endocrinology, neurology, gastroenterology, cognitive disorders, rheumatology and cardiovascular. Ipsen S.A. is headquartered in Boulogne-Billancourt, France.

See More

Key Turning Points

3rd Resistance Point 35.8233
2nd Resistance Point 35.6167
1st Resistance Point 35.3633
Last Price 35.1100
1st Support Level 34.9033
2nd Support Level 34.6967
3rd Support Level 34.4433

See More

52-Week High 38.9500
Last Price 35.1100
Fibonacci 61.8% 33.6631
Fibonacci 50% 32.0300
Fibonacci 38.2% 30.3969
52-Week Low 25.1100

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar